< Back to previous page
Researcher
van den Bosch Filip
- Disciplines:Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
Affiliations
- Elewaut Lab (Research group)
Member
From1 Jan 2017 → Today
Publications
1 - 10 of 87
- Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.(2024)
Authors: Filip Van den Bosch
Pages: 547-549 - Maximal exercise tolerance, objective trunk strength and mobility measurements in axial spondyloarthritis.(2024)
Authors: Filip Van den Bosch, Dirk Elewaut, Philippe Carron
Pages: e-pub - Association of anatomical variants of the sacroiliac joint with bone marrow edema in patients with axial spondyloarthritis.(2024)
Authors: Philippe Carron, Manouk de Hooge, Filip Van den Bosch, Dirk Elewaut
Pages: 507-514 - Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients.(2024)
Authors: Manouk de Hooge, Dirk Elewaut, Filip Van den Bosch
Pages: 194-198 - Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.(2023)
Authors: Filip Van den Bosch
Pages: 2122-2129 - ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.(2023)
Authors: Filip Van den Bosch, Philippe Carron, Manouk de Hooge
Pages: 19-34 - Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT.(2023)
Authors: Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Dirk Elewaut, Philippe Carron, Filip Van den Bosch
Pages: 1841-1850 - Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature.(2023)
Authors: Céline Mortier, Katrien Quintelier, Ann-Sophie De Craemer, Thomas Renson, Liselotte Deroo, Emilie Dumas, Zuzanna Lukasik, Sofie Van Gassen, Yvan Saeys, Filip Van den Bosch, et al.
Pages: 1969-1982 - Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.(2023)
Authors: Filip Van den Bosch
Pages: 80 - Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.(2023)
Authors: Dirk Elewaut, Filip Van den Bosch
Pages: 515-526